Clinical research

Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the NOYA I trial

EuroIntervention 2012;8:796-802. DOI: 10.4244/EIJV8I7A122

Bo Xu
Bo Xu1, MBBS; Kefei Dou1, MD, PhD; Yuejin Yang1, MD, PhD; Shuzheng Lv2, MD; Lefeng Wang3, MD; Haichang Wang4, MD; Zhanquan Li5, MD; Lei Wang6, MD; Yundai Chen7, MD; Yong Huo8, MD; Wei Li1, PhD; Ajay J. Kirtane9, MD, PhD; Runlin Gao1*, MD
1. Fuwai Hospital, National Centre for Cardiovascular Diseases of China, Beijing, China; 2. Affiliated Anzhen Hospital of Capital Medical University, Beijing, China; 3. Affiliated Chaoyang Hospital of Capital Medical University, Beijing

Aims: This study sought to evaluate the safety and efficacy of the NOYA stent which is a cobalt chromium-based sirolimus-eluting stent (SES) wit

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

biodegradable polymerin-stent late lumen lossnoya stentsafety
Read next article
Five-year clinical follow-up of unprotected left main bifurcation lesion stenting: one-stent versus two-stent techniques versus double-kissing crush technique

Latest news